Biostage Inc. closed a private placement of 302,115 common shares to raise $1 million in gross proceeds.

The stocks were sold at $3.31 apiece to Jinhui Liu.

Holliston, Mass.-based Biostage is developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea.